MSNBC American Voices With Alicia Menendez October 23, 2021 23:30:00
Major developments indicating we may closer to vaccinating younger kids against covid. the fda on friday explaining the benefits of the pfizer vaccine for children ages 5 to 11 outweigh the risks. the pfizer study found a 90% efficacy rate in preventing symptomatic cases. they will discuss emergency authorization for lower doses of pfizer for children. also this week, the cdc signing off on the fda's approval for moderna and johnson & johnson boosters. all johnson & johnson recipients over 18 years old will be eligible for a booster shot at least two months after their first shot. the moderna ...